We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EVK:XETREvonik Industries AG Analysis

Data as of 2026-05-21 - not real-time

€16.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Evonik (EVK) trades just above its identified support of €16.99 and below the 20‑day SMA of €17.63, indicating short‑term price pressure. The bullish trend flag is tempered by a bearish MACD histogram and a neutral RSI of 40, suggesting limited upside momentum in the near term. Volume is rising, which adds some confidence to the price holding its support, but the high P/E of ~50 and a negative revenue growth of 9.3% raise concerns about earnings sustainability. The dividend yield looks attractive at 5.9%, yet the payout ratio exceeds 300%, making the dividend financially untenable.
From a valuation perspective, the DCF‑derived fair value of €23.68 is well above the current price, implying a substantial upside potential if the company can improve cash generation and curb debt (DE/Equity ~46%). However, the sector’s inherent regulatory exposure, combined with a 30‑day volatility of 20.6% and modest beta, points to a medium‑to‑high risk profile. Investors should weigh the short‑term technical weakness against the longer‑term undervaluation and sector fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support
  • Bearish MACD divergence
  • Increasing volume but neutral RSI

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF upside to €23.68
  • Weak earnings and high payout ratio
  • Sector stability with moderate regulatory risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant undervaluation versus fair value
  • Potential for cash‑flow improvement and debt reduction
  • Specialty chemicals demand resilience

Key Metrics & Analysis

Financial Health

Revenue Growth-9.30%
Profit Margin1.14%
P/E Ratio50.0
ROE1.94%
ROA2.70%
Debt/Equity46.36
P/B Ratio1.0
Op. Cash Flow€1.5B
Free Cash Flow€1.1B

Technical Analysis

TrendBullish
RSI40.1
Support€16.99
Resistance€17.93
MA 20€17.63
MA 50€16.43
MA 200€15.11
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value€23.68
GradeUndervalued
TypeValue
Dividend Yield5.89%

Risk Assessment

Beta-0.08
Volatility20.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.